Zdrowie i gospodarka · 05/10/2009

FDA Releases Draft Guidance on H. pylori-Associated Duodenal Ulcer Disease Treatment

The FDA has made available a draft guidance document to help pharmaceutical companies develop effective treatments for adults with duodenal ulcers caused by H. pylori bacteria, with the goal of reducing ulcer recurrence.